O ne of the most important unresolved questions in contemporary coronary artery bypass (CABG) surgery is the choice of the conduit to complement the internal thoracic to left anterior descending artery anastomosis.
The radial artery (RA), the right internal thoracic artery (RITA), and the saphenous vein (SV) are all currently being used routinely, although the majority of the surgeons favor the SV.
Abundant observational evidence suggests a survival benefit for the use of arterial grafts, and the current guidelines encourage a wider use of the RA or the RITA, especially in patients with a long life expectancy. [1] [2] [3] [4] However, the reported benefit of arterial grafts has not been confirmed in a large randomized controlled trial (RCT) , and it has been hypothesized that the survival benefit seen in observational studies may be due to unmatched confounders and treatment allocation bias. 5, 6 An important additional unresolved question is the relative role of the RITA and RA. Although the RITA is biologically identical to the left internal thoracic artery, data comparing the patency rate and clinical outcome of the 2 arterial grafts has been contradictory and inconclusive. 7, 8 Network meta-analysis (NMA) with adjusted indirect comparison among treatments is a useful technique to reduce the potential for heterogeneity or allocation biases, in particular when analyzing both RCTs and observational studies. 9 To date, the only published NMA comparing the SV, RITA and RA as the second conduit in CABG focused only on angiographic patency and not on clinical outcomes. 10 Due to the well-known discrepancy between occlusion of grafts to non-left anterior descending arteries and clinical outcomes, 11 a similar analysis focusing on clinical end points is of particular relevance to the surgical community.
Here, we performed an NMA with the aim to specifically investigate the differences in late survival (primary outcome) and other clinical outcomes according to the type of second graft used for CABG.
Material and Methods
The authors declare that all supporting data are available within the article and its online supplementary files. This systematic review and NMA follows the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement. 12 
Data Sources and Systematic Literature Review
Ovid's version of MEDLINE and EMBASE were searched from inception to February 2018 (full search strategy attached in Table S1 ). Inclusion criteria were English language publications, adjusted or matched observational studies or RCTs comparing RA and/or SV and/or RITA as the second conduit for CABG. In addition, we searched recent meta-analyses and reviews on this topic for potential additional studies. All citations were reviewed by 3 investigators independently (A.A., A.D.F., and M.R.), and any disagreements were resolved by consensus. In case of overlapping studies, the largest series were included.
Data Extraction and Quality Assessment
Data extraction was performed independently by 2 investigators (A.A. and A.D.F.). The following variables were included: study demographics (sample size, number of centers, institutions involved, publication year, study period, design and country, length of follow-up), patient demographics (age, sex, diabetes mellitus, and ejection fraction) and procedural (use of skeletonization) and postoperative data. The quality of the included studies was assessed by the Newcastle-Ottawa Scale (Table S2) . 13 Only RCTs and observational studies of high quality (Newcastle-Ottawa Scale score >6) were included in the final analysis.
Outcomes
The primary outcome was all-cause long-term mortality. The secondary outcomes were operative mortality, perioperative stroke, perioperative myocardial infarction (MI), and deep sternal wound infection (DSWI), as defined in the original articles. Two levels of analyses were conducted for all outcomes: (1) pairwise meta-analysis between arterial grafts (with either RITA or RA) and SV and between RITA and RA, and (2) network meta-analyses between RITA, RA, and SV.
Data Synthesis and Analysis
Pairwise meta-analysis Late outcomes were pooled as the natural logarithm of the incident rate ratio (IRR) to account for potentially different follow-up durations between the groups. We estimated the IRR through several means depending on the available study data. When hazard ratios for matched (preferentially)/adjusted cohorts were provided, we took the natural logarithm
Clinical Perspective
What Is New?
• The use of the radial artery or the right internal thoracic artery is associated with a similar and statistically significant longterm clinical benefit compared with the saphenous vein.
• There are no differences in operative risk or complications between the two arterial conduits, but deep sternal wound infection remains a concern with bilateral internal thoracic artery when skeletonization is not used.
What Are the Clinical Implications?
• The results of our study support the superiority of the use of a second arterial over venous graft, and suggest the equivalence in long-term and perioperative outcomes among RITA and radial artery.
of the hazard ratio; the standard error was derived from the 95% CI or log rank P value. 14 When Kaplan-Meier curves were present, we estimated the event rates from the curves using GetData Graph Digitizer software 2.26 (http://getdata-graphdigitizer.com/). In case of missing Kaplan-Meier curves, we used the reported event rates in order to calculate the IRR, as previously described. 15, 16 Short-term binary outcomes were pooled using log odds ratio (OR) with 95% CI using the generic inverse variance method. 9 Random effect meta-analysis was performed using meta and metafor packages in R (version 3. 
Network meta-analysis
Network (multiple-treatment) meta-analysis was conducted in R (version 3.3.3 R Project for Statistical Computing) using the "netmeta" statistical package based on the method described by R€ ucker. [23] [24] [25] Inconsistency was evaluated with Cochran's Q. 26 Pooled log IRRs with 95% CIs was used to determine the relative effect estimates of late outcomes. ORs with 95% CIs were used for the binary outcomes. A random-effects model was preferentially used to improve the model fit, but results using a fixed model were also reported. Inconsistency in NMA was evaluated by conducting conventional pairwise meta-analyses and testing consistency by comparing the direct and indirect evidence. The consistency equation used was lBC=lACÀlAB, where lAB is the treatment effect for treatment B compared with treatment A. 27, 28 We used Cochran's Q statistic to assess inconsistency, and the presence of P<0.05 signifies inconsistency. Statistical significance (at the 5% level) was declared when 95% CI did not cross the line of no effect. For the primary outcome, a network meta-regression was used to relate the size of treatment effect to potential effect modifiers (mean age, percentage of female, percentage of patients with diabetes mellitus, and mean preoperative ejection fraction). Network meta-regression was conducted using the logit transformation method with random-effects model with no priori. The logit transformation was used as suggested by other authors.
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Results
Description of the Included Studies and of the Population
A total of 2455 studies were retrieved and 35 met inclusion criteria and were included in the final meta-analysis (Figure S1 ). Seven studies were international and multicenter; 11 studies were from the United States; 4 from Canada, 3 each from Italy and the United Kingdom; 2 each from Japan and Australia, and 1 each from Austria, Serbia, and Argentina (Tables 1 and 2 ). 
Pairwise Meta-Analysis
The main results of the pairwise meta-analysis are summarized in Table 3 .
At a mean follow-up of 6.9 years, the use of any arterial graft (RA or RITA) was associated with lower long-term mortality compared with the use of the SV (IRR, 0.80; 95% CI, 0.75-0.85). There was a significantly higher risk of DSWI (OR 1.27; 95% CI, 1.05-1. When directly comparing the 2 arterial grafts, the use of RITA was associated with similar long-term mortality (IRR, 0.96; 95% CI, 0.83-1.11) at 7.1 years' mean follow-up compared with the RA. The risk of perioperative MI (OR, 0.32; 95% CI, 0.03-3.13) and perioperative stroke (OR, 0.87; 95% CI, 0.45-1.68) were similar between the 2 arterial grafts. There was a significantly higher risk of DSWI (OR, 2.22; 95% CI, 1.09-4.54) and operative mortality (OR, 1.76, 95% CI, 1.21-2.55) in the RITA group. When limiting the analysis to the studies where the skeletonization technique was used for ITA harvesting, no difference in DSWI between the RA and RITA groups was found ( Figure S2) .
A subgroup analysis for the primary outcome comparing the results of RCT versus non-RCT studies is provided in Figure S3 .
Leave-one-out analysis was robust for the primary outcome in the main analysis (arterial grafts versus SV ( Figure S4A ). Funnel plot Egger's test intercept for the primary outcome in arterial versus venous comparison was À0.64AE0.46, P=0.17 ( Figure S4B ).
Network Meta-Analysis
The results of the NMA are summarized in Figure and Tables  S3 and S4 . The use of the RITA was associated with similar late mortality (IRR, 0.98; 95% CI, 0.89-1.07) and perioperative MI (OR, 1.01; 95% CI, 0.62-1.65) compared with the RA. There was a trend toward higher risk of DSWI in the RITA group (OR, 1.39; 95% CI, 0.92-2.1), while operative mortality and stroke were similar for the 2 arteries.
At network meta-regression, mean age, percentage of female, percentage of patients with diabetes mellitus, and mean preoperative ejection fraction were not found to significantly modify the treatment effect ( Figure S5 ).
Discussion
The balance between possible better long-term clinical and angiographic outcomes of arterial grafts and the potential risk of harvesting site complications and the increased technical complexity associated with their use has been the center of a continuous debate over the past 25 years. 66 Also, the relative CAT indicates reported as categories; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; EF, ejection fraction; LCX, left circumflex artery territory; MultiArt, multiple arterial grafting group; NR, not reported; ONCAB, on-pump coronary artery bypass; OPCAB, off-pump coronary artery bypass; RA, radial artery; RCA, right coronary artery territory; RITA, right internal thoracic artery; SV, saphenous vein.
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Journal of the American Heart Association efficacy of the RITA and RA as the second arterial grafts remains controversial. 7 Several pairwise meta-analyses on the topic have been published previously. 1, 67, 68 However, pairwise meta-analyses have known limitations in terms of heterogeneity of the included studies and potential for treatment allocation bias. NMAs have been proposed to overcome the limitations of the pairwise comparison, especially when summarizing the evidence of RCTs and observational studies. 9, 69 It has been suggested that NMA can be superior to classical pairwise analyses, especially in case of comparison of a new treatment to a standard one. 70 This is the first NMA specifically addressing the differences in clinical outcomes according to the type of second graft used for CABG. The only published network meta-analysis on the subject focused only on the patency rates of conduits and did not include clinical outcomes. 10 Due to the demonstrated absence of a consistent correlation between angiographic failure and clinical events, 11 a deeper understanding of the clinical impact of the type of second conduit used for CABG seems of major relevance. The results of our study support the superiority of the use of a second arterial over venous graft, and suggest the equivalence in long-term and perioperative outcomes between the RITA and RA.
The superior midterm patency rate of arterial grafts (especially the RA) has been convincingly demonstrated in RCTs and observational studies. 50, [71] [72] [73] [74] A large amount of observational evidence also suggests a clinical benefit in terms of survival and event-free survival for the use of the RA However, we have recently shown how unmatched confounders are present even in the best comparative observational studies and suggested that a treatment allocation bias may be responsible for the better clinical outcome of patients receiving more than 1 arterial graft. 6 This type of bias is potentially present even in the present meta-analysis, but the additional power and precision of NMA in defining relations and interactions between treatments from the aggregated estimates of all the available evidence should permit a more efficient comparison among different strategies. 9 Our results are in line with those of a recent patient-level meta-analysis on the comparison between the RA and the SV. 76 However, at first sight, our results appear to contradict the overall neutral findings of the ART (Arterial Revascularization Trial), where on the primary intention-to-treat analysis, there was no difference in survival between single and bilateral ITA grafts at 10 years (in press). However, 40% of patients in the ART received a different treatment from that initially proposed and an as-treated analysis showed a significant survival benefit in patients receiving >1 arterial graft, consistent with the results of the current study. Difference in sample size and length of follow-up and the fact that in observational studies the revascularization strategy is based on surgical judgment and not mandated by protocol are possible explanations for these apparent contradictions.
A key finding of this study is the demonstration of equivalence between the RITA and RA with respect to all the short-and long-term clinical outcomes. Of note, in our analysis, the relative survival benefit of the RITA and RA compared with the SV were identical (SV versus RITA and RA, IRR, 1.26; 95% CI, 1.17-1.35). Although there was a trend toward higher risk of DSWI with RITA, this risk became nonsignificant in a subgroup analysis of studies where the skeletonization of ITA was employed. This finding is in accordance with what was reported by previous metaanalyses 7 and by a post hoc analysis of the ART. 77 The literature on the comparison between the RITA and RA is discordant. We previously published a pairwise metaanalysis of the propensity-matched studies comparing the 2 arterial grafts and found that the use of the RITA was associated with a 25% relative reduction in the risk of longterm mortality. 7 The reason underlying the discrepancy between our previous meta-analysis and the present findings is probably related to the different sample size (149 902 patients with 6.9 years of follow-up for the present analysis versus 15 374 patients and a range of 45-168 months of follow-up for the previous pairwise comparison). Also, our previous analysis did not include 2 recent large studies comparing the 2 arterial grafts. 33, 78 Finally, the use of NMA and direct/indirect comparisons allow for better precision around estimates compared with pairwise comparisons. Of note, in a large study the Society of Thoracic Surgeons National Database of >1.4 million patients, Schwann et al 8 showed significantly higher perioperative mortality and risk of DSWI using the RITA, but not the RA, versus the SV as the second graft-findings that were also demonstrated in the present study. The authors also described a significant volume-to-outcome relation for the use of the RITA but not of the RA. Similarly, in a meta-analysis of 34 bilateral internal thoracic artery (BITA) series and 27 000 BITA patients, we recently identified a highly significant BITA use-to-outcome relationship for long-term survival and incidence of DSWI that was independent from the well-known CABG volume/outcome effect. 78 These findings suggest that BITA grafting may be more technically demanding than the use of the single internal thoracic artery and that a volume/outcome relation can explain the marginally increased operative risk in the RITA arm.
A key point when using the RA for CABG is the degree of target vessel stenosis. It has been shown that the patency rate of RA grafts is strongly influenced by the degree of target coronary stenosis. [79] [80] [81] In fact, a target vessel stenosis >70% was a common criterion for using the RA in the studies included in this meta-analysis (Table 2) . This study shares the usual limitations of meta-analyses of observational studies. 82 Despite statistical adjustment and the use of NMA, between-studies heterogeneity remains a source of bias. Important details such as the etiology of follow-up of death, the protocols used to reduce the risk of DSWI (with the exception of skeletonization of the ITA), and the incidence of repeat revascularization were not systematically retrievable and could not be included in our analyses. Additionally, we recognize that despite including only adjusted studies, the presence of unmeasured confounders and treatment allocation biases cannot be excluded. 6 However, the NMA approach utilized and the low-moderate-grade heterogeneity found across the studies should have attenuated these biases.
In conclusion, in an NMA of adjusted observational and randomized studies comparing the RA, the RITA, and the SV as the second conduit for CABG, we found that the use of the RITA or the RA was associated with a similar long-term clinical benefit compared with the use of the SV. No differences in late and operative mortality and postoperative complications was found between the 2 arterial conduits, although DSWI remains a concern after BITA grafting if skeletonization is not used.
Disclosures
None. Table S4 . Rank scores with probability rank of different graft groups with the greatest reduction in outcomes within the different treatment groups (RITA, RA and SV) where the closer to one equates to the probability the therapy leads to the greatest reduction. 
